S. Davis

发表

Pathologic response to neoadjuvant treatment in locally advanced rectal cancer and impact on outcome.

M. Mohebbi, S. Warrier, R. Wale, 2016, Journal of gastrointestinal oncology.

Radiotherapy in well‐differentiated thyroid cancer: is it underutilized?

S. Davis, Kevin So, Robin E Smith, 2016, ANZ journal of surgery.

The influence of pretreatment optimism on outcome in patients given radical radiotherapy for non-small cell lung cancer

R. Borland, D. Joseph, D. Ball, 2000 .

Risk and response adapted therapy for early stage Hodgkin lymphoma: a prospective multicenter study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group

J. Reynolds, D. Goldstein, D. Joseph, 2011, Leukemia & lymphoma.

A Prospective, Multicenter Study of Involved-Field Radiation Therapy With Autologous Stem Cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma (ALLG HDNHL04/TROG 03.03).

H. Prince, D. Zannino, D. Roos, 2019, International journal of radiation oncology, biology, physics.

Quality assurance experience with the randomized neuropathic bone pain trial (Trans-Tasman Radiation Oncology Group, 96.05).

P. Hoskin, D. Ball, N. Spry, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Optimal scheduling to reduce morbidity of involved field radiotherapy with transplantation for lymphomas: A Prospective Australasian Leukaemia and Lymphoma Group Study

J. Szer, D. Roos, A. Wirth, 2005, Bone Marrow Transplantation.

Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03.

R. Tsang, D. Joseph, R. Fisher, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High neutrophil‐to‐lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy

A. Haydon, S. Davis, Sahan Chandrasekara, 2018, Asia-Pacific journal of clinical oncology.

Value of low-dose 2 x 2 Gy palliative radiotherapy in advanced low-grade non-Hodgkin's lymphoma.

M. MacManus, M. Ng, G. Ryan, 2006, Australasian radiology.

Radiotherapy for early infradiaphragmatic Hodgkin's disease: the Australasian experience.

R. Fisher, J. Boyages, D. Joseph, 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiation therapy for early stage Hodgkin's disease: Australasian patterns of care. Australasian Radiation Oncology Lymphoma Group.

R. Fisher, J. Boyages, D. Joseph, 1995, International journal of radiation oncology, biology, physics.

Taxanes for the adjuvant treatment of early breast cancer: systematic review and economic evaluation.

S. Ward, A. Rees, D. Hind, 2007, Health technology assessment.

A prospective trial of short-fractionation radiotherapy for the palliation of liver metastases.

N. Spry, M. Poulsen, B. Burmeister, 2003, Australasian radiology.

A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma-Trans Tasman Radiation Oncology Group (TROG) Study 96.06.

N. Spry, B. Burmeister, Carol Johnson, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiation therapy following nodal surgery for melanoma: An analysis of late toxicity

B. Smithers, N. Spry, B. Smithers, 2002, ANZ journal of surgery.

Superior vena cava syndrome caused by an intrathoracic plasmacytoma

I. L. Roux, H. King, S. Davis, 1991, Cancer.

Mantle irradiation alone for clinical stage I-II Hodgkin's disease: long-term follow-up and analysis of prognostic factors in 261 patients.

K. Yuen, J. Corry, G. Ryan, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Optimism and survival in lung carcinoma patients

R. Borland, D. Joseph, D. Ball, 2004, Cancer.

A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer: an interim toxicity analysis of the first 100 patients.

D. Joseph, D. Ball, G. Ryan, 1995, International journal of radiation oncology, biology, physics.

A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial.

D. Joseph, D. Ball, I. Olver, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A phase III study of radiotherapy with and without continuous-infusion fluorouracil as palliation for non-small-cell lung cancer.

M. Millward, D. Ball, I. Olver, 1997, British Journal of Cancer.

231A phase III study of conventional and accelerated radiotherapy (RT) with and without carboplatin in unresectable non small cell lung cancer (NSCLC)

D. Joseph, D. Ball, I. Olver, 1996 .

Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03.

R. Tsang, D. Joseph, R. Fisher, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiotherapy in orbital lymphoma: optimizing the backbone to build upon

H. Quach, S. Davis, 2013, Leukemia & lymphoma.